Prescription drug · ANDA
Chlorpromazine Hydrochloride NDC 70710-1850
Chlorpromazine hydrochloride 25 mg/mL · Injection · Intramuscular · Zydus Pharmaceuticals USA Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70710-1850-7 | 70710185007 | 25 VIAL in 1 CARTON (70710-1850-7) / 2 mL in 1 VIAL (70710-1850-1)Marketed from Mar 29, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Chlorpromazine Hydrochloride
- Generic name (nonproprietary)
- chlorpromazine hydrochloride
- Active ingredients
- Chlorpromazine hydrochloride — 25 mg/mL
- Dosage form
- Injection
- Route
- Intramuscular
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 217275
- Marketing start
- Listing expires
- Other FDA classes
- Phenothiazines (Chemical structure)
- Identifiers
- Product ID 70710-1850_97106093-2f0a-4cc9-b580-942b015c6c5bSPL ID 97106093-2f0a-4cc9-b580-942b015c6c5bSPL set ID 7cd6dc0d-e98d-40ae-80d4-c15f63056abfRxCUI 1730076, 1730078UNII 9WP59609J6
- Pharmacologic class
- Phenothiazine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470710185007followed by a unit qualifier and the quantityPackage 70710-1850-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE For the treatment of schizophrenia; to control nausea and vomiting; for relief of restlessness and apprehension before surgery; for acute intermittent porphyria; as an adjunct in the treatment of tetanus; to control the manifestations of the manic type of manic-depressive illness; for relief of intractable hiccups; for the treatment of severe behavioral problems in children (1 year to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the fo…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 217275
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 25 mg/mL | InjectionIntramuscular | Zydus Pharmaceuticals USA Inc. | 70710-1849 |
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 25 mg/mL | InjectionIntramuscular | Zydus Lifesciences Limited | 70771-1778 |
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 25 mg/mL | InjectionIntramuscular | Zydus Lifesciences Limited | 70771-1779 |